Child Obesity — Causes, Health Risks & Treatment Guide — Symptoms, Causes & Treatment | MyMedicPlus

Child obesity is defined as excess body fat accumulation that presents a risk to health, operationally defined as a BMI-for-age at or above the 95th percentile for sex using age-appropriate reference charts (CDC or WHO growth charts). Overweight in children is defined as BMI-for-age at or above the 85th but below the 95th percentile. Unlike in adults, a fixed BMI cut-off is inappropriate for children given the normal variation of body composition with age and sex — hence the use of centile-based definitions. Childhood obesity affects approximately 390 million children and adolescents aged 5-19 years globally, and its prevalence has tripled since 1975. It is not a cosmetic issue but a significant metabolic disorder with well-documented consequences including type 2 diabetes, hypertension, dyslipidaemia, non-alcoholic fatty liver disease, sleep apnoea, orthopaedic complications, and psychological comorbidities including depression, anxiety, and bullying. Obesity is the most common nutritional disorder in children in high-income countries and is increasingly prevalent in middle- and low-income countries undergoing nutritional transition.

Child obesity results from a chronic positive energy balance (energy intake exceeding energy expenditure), influenced by a complex interaction of genetic, epigenetic, behavioural, and environmental factors. Genetic: heritability estimates of 40-70% — over 1,000 genetic loci have been associated with BMI. Monogenic obesity (rare, highly penetrant mutations in MC4R, LEPR, LEP, PCSK1 — leptin-melanocortin pathway genes) accounts for under 5% but presents with severe early-onset obesity. Common polygenic risk confers susceptibility but requires obesogenic environments to manifest. Epigenetic: maternal obesity, gestational diabetes, excessive gestational weight gain, and maternal smoking during pregnancy increase child obesity risk through epigenetic programming. Dietary factors: high consumption of ultra-processed foods (high energy density, low satiety, palatable), sugar-sweetened beverages (SSB — strongest dietary evidence for weight gain), large portion sizes, high-fat diets, and frequent fast food consumption. Physical inactivity: sedentary screen time (television, gaming, smartphones) — children spending over 3 hours/day on screens have twice the obesity risk of those spending under 1 hour; reduced active transport; neighbourhood safety affecting outdoor play. Sleep deprivation: each hour of reduced sleep in children increases obesity risk by 30% — sleep affects ghrelin (hunger hormone) and leptin (satiety hormone). Secondary causes (less than 5%): hypothyroidism, Cushing's syndrome, growth hormone deficiency, hypothalamic obesity (after brain tumours or cranial irradiation), genetic syndromes (Prader-Willi syndrome, Bardet-Biedl syndrome), and medications (corticosteroids, antipsychotics, anticonvulsants).

Child obesity itself presents with increased body weight and adiposity, but the clinical concern lies in the associated comorbidities. Metabolic: insulin resistance (acanthosis nigricans — dark, velvety thickening of skin in neck folds and axillae — a visible marker of insulin resistance), type 2 diabetes (formerly 'adult-onset diabetes' — increasingly diagnosed in obese adolescents), prediabetes (impaired fasting glucose or impaired glucose tolerance), and metabolic syndrome (combination of abdominal obesity, hypertension, dyslipidaemia, and impaired glucose metabolism). Cardiovascular: elevated blood pressure (hypertension affects 30-40% of obese children), dyslipidaemia (elevated triglycerides, low HDL — 'atherogenic lipid profile'), and early atherosclerotic changes. Hepatic: non-alcoholic fatty liver disease (NAFLD) — fatty infiltration of the liver — affects up to 40% of obese children; may progress to NASH (non-alcoholic steatohepatitis) with fibrosis. Respiratory: obstructive sleep apnoea (12-22% of obese children — snoring, witnessed apnoeic episodes, behavioural changes, school performance decline), and obesity hypoventilation. Orthopaedic: Blount's disease (tibia vara), slipped capital femoral epiphysis (SCFE — sudden groin or knee pain in obese adolescent — orthopaedic emergency), genu valgum, and flat feet. Psychological: depression, anxiety, low self-esteem, and bullying (both as victim and perpetrator) are more prevalent — social stigma causes significant harm.

BMI is calculated as weight (kg) divided by height squared (m²) and plotted on sex-specific age-appropriate growth charts. BMI-for-age above the 95th percentile defines obesity; above the 85th percentile defines overweight. Waist circumference above the 90th percentile for age and sex identifies central adiposity and metabolic risk better than BMI alone. Blood pressure should be measured using an appropriately sized cuff. Investigation for comorbidities in obese children aged 10 and over (or younger if significant risk factors): fasting blood glucose and HbA1c (diabetes screening); fasting lipid profile (total cholesterol, LDL, HDL, triglycerides); liver function tests (elevated ALT suggests NAFLD); thyroid function tests (TSH — to exclude hypothyroidism); fasting insulin and HOMA-IR (insulin resistance index). Abdominal ultrasound if NAFLD is suspected (elevated ALT). Polysomnography (sleep study) for suspected obstructive sleep apnoea. Investigations for secondary causes (undertaken based on clinical features): cortisol, ACTH, growth hormone, karyotype (Turner syndrome, Klinefelter syndrome). Consideration of genetic testing for MC4R mutations in severe early-onset hyperphagia.

Family-based behavioural lifestyle intervention (FBL) is the first-line and most evidence-based treatment — involving child and parents together, targeting dietary change (balanced nutrition, reduced ultra-processed food and SSB, appropriate portion sizes), increased physical activity (at least 60 minutes of moderate-to-vigorous aerobic activity daily), reduced sedentary screen time (under 2 hours/day for school-age children), improved sleep (9-11 hours for primary school children, 8-10 hours for adolescents), and behavioural strategies (self-monitoring, goal setting, problem solving). FBL is most effective when intensive (over 26 hours of contact over 6-12 months) and delivered by a multidisciplinary team (dietitian, psychologist, exercise specialist, paediatrician). Pharmacological treatment (reserved for severe obesity or significant comorbidities not responding to lifestyle intervention): metformin — reduces insulin resistance and modest weight reduction (evidence in adolescents); orlistat (pancreatic lipase inhibitor — reduces fat absorption) approved in adolescents over 12 in some guidelines; GLP-1 receptor agonists: liraglutide (approved in adolescents over 12 in US and EU), semaglutide (weekly SC injection — approved for adolescent obesity in the US with significant efficacy — 16% body weight reduction at 68 weeks). Bariatric surgery (gastric sleeve, Roux-en-Y gastric bypass) for adolescents over 13-16 with severe obesity (BMI >40 or >35 with serious comorbidities) who have failed lifestyle and pharmacological interventions — produces sustained weight loss and resolution of metabolic comorbidities but requires lifelong follow-up.

Childhood obesity causes significant physical and psychological complications, many of which persist into adulthood. Type 2 diabetes: obese adolescents are at dramatically elevated risk — in the US, type 2 diabetes in youth has risen 5-fold since 1990; youth-onset type 2 diabetes develops diabetic complications faster than adult-onset. Hypertension (affecting 30-40% of obese children) causes early endothelial damage — carotid intima-media thickness (CIMT) studies show premature atherosclerosis beginning in childhood. Non-alcoholic fatty liver disease (NAFLD) progresses to non-alcoholic steatohepatitis (NASH) with fibrosis in up to 10% — potentially requiring liver transplantation in adulthood. Orthopaedic complications: slipped capital femoral epiphysis (SCFE — acute hip pain, a paediatric emergency), Blount's disease (tibial bowing), and early joint degeneration from excess skeletal loading during growth. Obstructive sleep apnoea (affecting 12-22%) causes sleep fragmentation, behavioural problems, and academic underperformance. Polycystic ovary syndrome (PCOS) affects up to 30-40% of adolescent girls with obesity. Psychological complications: clinical depression, anxiety, poor self-esteem, and disordered eating significantly impair quality of life. Tracking into adulthood: 70-80% of obese adolescents become obese adults, compounding lifetime cardiometabolic risk.

Prevention must be multisectoral — no single intervention is sufficient. Breastfeeding for at least 6 months is associated with a 15-30% reduction in later childhood obesity risk. Introduction of healthy complementary feeding from 6 months, avoiding added sugars before age 2 (WHO recommendation). Limit free sugars to under 10% of total energy intake (WHO). Reduce sugar-sweetened beverage consumption — SSB taxes implemented in various countries have reduced SSB consumption. School food standards ensuring nutritious meals, eliminating SSBs from vending machines, and mandatory daily physical activity (at least 60 minutes). Screen time limits: under 1 hour per day for 3-4 year olds; under 2 hours for older children. Safe parks, cycling infrastructure, and active transport facilitate physical activity for children. Early identification: BMI-for-age monitoring at child health reviews (ages 2, 4, and school entry). Primary care and public health interventions are more effective than clinical interventions alone. Government policies (sugar taxes, food labelling, marketing restrictions to children, urban planning) are essential for sustainable population-level change.

Seek urgent evaluation for: a child with obesity who has sudden onset of groin, hip, or knee pain with difficulty walking — this may indicate slipped capital femoral epiphysis (SCFE), which requires immediate orthopaedic assessment; witnessed sleep apnoea (prolonged pauses in breathing during sleep), excessive daytime sleepiness, or significant behavioural deterioration from sleep disruption. Seek routine paediatric assessment for: any child whose BMI is above the 95th percentile for age and sex; dark velvety skin changes in neck folds (acanthosis nigricans indicating insulin resistance); unexplained rapid weight gain with short stature (possible Cushing's syndrome or hypothyroidism — requires endocrine evaluation); signs of depression, social withdrawal, or bullying linked to weight. Overweight children with family history of type 2 diabetes, cardiovascular disease, or hypertension should be referred to a paediatric dietitian and have blood glucose and lipids measured annually.